Registry collecting clinical and imaging data for brain glioma patients
Official title: Registry Describing Clinical Information, Conventional, and Advanced Magnetic Resonance Imaging Information of Patients With Brain Glioma
Run by Asan Medical Center · NCT02619890 · Data updated 2026-11-12
This study is collecting medical and MRI information from patients with brain gliomas to see how well treatments are working and to improve care over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 9000 (estimated) |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | September 2015 |
| Main results expected | December 2040 |
| Study ends | December 2040 |
| Registry record updated | May 14, 2024 |
| Trial ID | NCT02619890 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults with a confirmed diagnosis of brain glioma who are undergoing first- or second-line therapy and have a life expectancy of more than three months.
✕Probably not a fit
Patients without brain gliomas or those with certain bioimplants that may interfere with MRI procedures will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects clinical and advanced MRI data from patients diagnosed with brain gliomas, including both low-grade and glioblastoma types. It aims to monitor treatment responses and long-term outcomes using multimodal advanced MR imaging techniques such as diffusion-weighted imaging and chemical exchange saturation transfer imaging. By creating a comprehensive database, the registry seeks to identify potential imaging biomarkers that could aid in assessing treatment efficacy and improving patient care over time.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of brain glioma treatment responses and lead to improved patient outcomes through better imaging biomarkers.
How similar studies have gone: While the approach of using advanced MRI techniques in glioma research is established, the specific registry format for long-term follow-up is a novel initiative.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients must have radiologically and histologically confirmed diagnosis of Brain Glioma * Life expectancy of greater than 3 months * Must receive a first- or second-line therapy * Signed informed consent Exclusion Criteria: * No brain gliomas * Patients who have any type of bioimplant activated by mechanical, electronic, or magnetic means (e.g., cochlear implants, pacemakers, neurostimulators, biostimulates, electronic infusion pumps, etc), because such devices may be displaced or malfunction * Patients who are pregnant or breast feeding; urine pregnancy test will be performed on women of child bearing potential
Where it's running
-
Asan Medical Center
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Ho Sung Kim, M.D.,Ph.D.
- Email: radhskim@gmail.com
- Phone: +82230105682
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adding triapine to radiation therapy for recurrent glioblastoma and astrocytoma
This early-phase study tests whether giving the drug triapine together with radiation is safe and tolerable for adults whose glioblastoma or astrocytoma has come back.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.